SCP-3 Inhibitors
SCP-3 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of SCP-3, also known as Synaptonemal Complex Protein 3, which is a crucial component of the synaptonemal complex. The synaptonemal complex is a proteinaceous structure that forms between homologous chromosomes during the prophase of meiosis I, facilitating chromosome pairing, synapsis, and recombination. SCP-3 plays a pivotal role in stabilizing the synaptonemal complex and ensuring the proper alignment of homologous chromosomes, which is essential for accurate chromosomal segregation during meiosis. By inhibiting SCP-3, researchers can disrupt the formation and function of the synaptonemal complex, allowing for the study of the molecular mechanisms that govern meiotic chromosome dynamics and genetic recombination.
In research, SCP-3 inhibitors are valuable tools for dissecting the processes of meiosis and understanding how the synaptonemal complex contributes to genetic diversity through recombination. By blocking SCP-3, scientists can investigate the consequences of impaired synapsis, such as defective chromosome pairing and mis-segregation, which can lead to aneuploidy or other chromosomal abnormalities. These inhibitors help to elucidate the role of SCP-3 in maintaining the integrity of the synaptonemal complex and ensuring the fidelity of genetic exchange during meiosis. Additionally, SCP-3 inhibitors allow researchers to explore the interactions between SCP-3 and other components of the synaptonemal complex, shedding light on the coordinated actions of these proteins in promoting homologous recombination. Through these studies, SCP-3 inhibitors contribute to a deeper understanding of the molecular mechanisms underlying meiotic chromosome behavior, the regulation of genetic recombination, and the broader implications of synaptonemal complex function in reproductive biology. This knowledge is critical for advancing the field of genetics and understanding the fundamental processes that drive genetic variation and inheritance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
It may inhibit DNA methyltransferases, potentially leading to changes in chromatin structure and reduced transcription of genes including SCP3. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it can alter chromatin structure and potentially downregulate SCP3 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
By intercalating into DNA and inhibiting RNA polymerase, it could decrease SCP3 mRNA synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
It inhibits protein synthesis, potentially leading to a decrease in SCP3 levels if applied during its expression window. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
It inhibits mTOR, which can lead to altered protein synthesis rates, possibly affecting SCP3 levels. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
By inhibiting DNA topoisomerase I, it can disrupt DNA replication and transcription, potentially reducing SCP3 expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
It intercalates into DNA and disrupts topoisomerase II function, potentially reducing SCP3 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, it could alter signal transduction pathways, potentially leading to reduced SCP3 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
It inhibits PI3K, which could lead to changes in various signaling pathways and potentially reduce SCP3 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting MEK, it could affect MAPK signaling and potentially downregulate SCP3 expression. | ||||||